Korean Journal of Radiology

  • 제13권5호
  • /
  • Pages.618-624
  • /
  • 2012
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

Uterine Artery Embolization for Symptomatic Fibroids with High Signal Intensity on T2-Weighted MR Imaging

  • Chang, Suyon (Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Severance Hospital) ;
  • Kim, Man-Deuk (Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Severance Hospital) ;
  • Lee, Myungsu (Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Severance Hospital) ;
  • Lee, Mu Sook (Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Severance Hospital) ;
  • Park, Sung Il (Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Severance Hospital) ;
  • Won, Jong Yun (Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Severance Hospital) ;
  • Lee, Do Yun (Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Severance Hospital) ;
  • Lee, Kwang Hun (Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Severance Hospital)
  • 발행 : 2012.10.01
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: To evaluate the effectiveness of uterine artery embolization (UAE) for treating symptomatic fibroids with high signal intensity (SI) on magnetic resonance (MR) T2-weighted imaging (T2WI). Materials and Methods: A total of 537 cases, consisting of 14 patients with high SI fibroids on T2WI (T2 high group), were retrospectively included and compared with 28 randomly selected patients with low SI fibroids on T2WI (control group). High SI of a predominant fibroid on T2WI was defined as having the same or higher SI than the myometrium. Patient ages ranged from 28 to 52 years (mean, 38.1 years). All patients underwent MRI before and after UAE. Predominant fibroid and uterine volumes were calculated with MR images. Symptom status in terms of menorrhagia and dysmenorrhea was scored on a scale of 0-10, with 0 being no symptoms and 10 being the baseline, or initial symptoms. Results: Of the patients in the T2 high group, 13 out of 14 (92.9%) patients demonstrated complete necrosis of the predominant fibroids. The mean volume reduction rates of the predominant fibroids in the T2 high group was 61.7% at three months after UAE, which was significantly higher than the volume reduction rates of 42.1% noted in the control group (p < 0.05). Changes in symptom scores for menorrhagia and dysmenorrhea after UAE (baseline score minus follow-up score) were 4.9 and 7.5 in T2 high group and they were 5.0 and 7.7 in control group, suggesting a significant resolution of symptoms (p < 0.01) in both groups but no significant difference between the two groups. Conclusion: UAE is effective for uttering fibroids showing high SI on T2WI. The mean volume reduction rate of the predominant fibroids three months after UAE was greater in the T2 high group than in the control group.

키워드

참고문헌

  1. Walker WJ, Pelage JP. Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG 2002;109:1262-1272 https://doi.org/10.1046/j.1471-0528.2002.01449.x
  2. Spies JB, Ascher SA, Roth AR, Kim J, Levy EB, Gomez-Jorge J. Uterine artery embolization for leiomyomata. Obstet Gynecol 2001;98:29-34 https://doi.org/10.1016/S0029-7844(01)01382-5
  3. Hovsepian DM, Siskin GP, Bonn J, Cardella JF, Clark TW, Lampmann LE, et al. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. J Vasc Interv Radiol 2009;20(7 Suppl):S193-S199 https://doi.org/10.1016/j.jvir.2009.04.006
  4. Funaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol 2009;34:584-589 https://doi.org/10.1002/uog.7455
  5. Oguchi O, Mori A, Kobayashi Y, Horiuchi A, Nikaido T, Fujii S. Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy: correlation between T2-weighted images and effect of GnRH analogue. J Obstet Gynaecol (Tokyo 1995) 1995;21:107-117
  6. Takahashi K, Okada M, Imaoka I, Sugimura K, Miyazaki K. Value of magnetic resonance imaging in predicting efficacy of GnRH analogue treatment for uterine leiomyoma. Hum Reprod 2001;16:1989-1994 https://doi.org/10.1093/humrep/16.9.1989
  7. Harman M, Zeterog˘lu S, Arslan H, Sengül M, Etlik O. Predictive value of magnetic resonance imaging signal and contrast-enhancement characteristics on post-embolization volume reduction of uterine fibroids. Acta Radiol 2006;47:427-435 https://doi.org/10.1080/02841850600557117
  8. Swe TT, Onitsuka H, Kawamoto K, Ueyama T, Tsuruchi N, Masuda K. Uterine leiomyoma: correlation between signal intensity on magnetic resonance imaging and pathologic characteristics. Radiat Med 1992;10:235-242
  9. Murase E, Siegelman ES, Outwater EK, Perez-Jaffe LA, Tureck RW. Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment. Radiographics 1999;19:1179-1197 https://doi.org/10.1148/radiographics.19.5.g99se131179
  10. Burn PR, McCall JM, Chinn RJ, Vashisht A, Smith JR, Healy JC. Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries. Radiology 2000;214:729-734 https://doi.org/10.1148/radiology.214.3.r00fe07729
  11. Orsini LF, Salardi S, Pilu G, Bovicelli L, Cacciari E. Pelvic organs in premenarcheal girls: real-time ultrasonography. Radiology 1984;153:113-116 https://doi.org/10.1148/radiology.153.1.6473771
  12. Spies JB, Spector A, Roth AR, Baker CM, Mauro L, Murphy-Skrynarz K. Complications after uterine artery embolization for leiomyomas. Obstet Gynecol 2002;100(5 Pt 1):873-880 https://doi.org/10.1016/S0029-7844(02)02341-4
  13. Goodwin SC, Bonilla SM, Sacks D, Reed RA, Spies JB, Landow WJ, et al. Reporting standards for uterine artery embolization for the treatment of uterine leiomyomata. J Vasc Interv Radiol 2001;12:1011-1020 https://doi.org/10.1016/S1051-0443(07)61586-3
  14. Yamashiro T, Gibo M, Utsunomiya T, Murayama S. Huge uterine leiomyoma with adenomyotic cysts mimicking uterine sarcoma on MR imaging. Radiat Med 2007;25:127-129 https://doi.org/10.1007/s11604-006-0106-2
  15. Hamlin DJ, Pettersson H, Fitzsimmons J, Morgan LS. MR imaging of uterine leiomyomas and their complications. J Comput Assist Tomogr 1985;9:902-907 https://doi.org/10.1097/00004728-198509000-00012
  16. Ueda H, Togashi K, Konishi I, Kataoka ML, Koyama T, Fujiwara T, et al. Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics 1999;19 Spec No:S131-S145 https://doi.org/10.1148/radiographics.19.suppl_1.g99oc04s131
  17. Rajan DK, Margau R, Kroll RR, Simons ME, Tan KT, Jaskolka JD, et al. Clinical utility of ultrasound versus magnetic resonance imaging for deciding to proceed with uterine artery embolization for presumed symptomatic fibroids. Clin Radiol 2011;66:57-62 https://doi.org/10.1016/j.crad.2010.08.005
  18. deSouza NM, Williams AD. Uterine arterial embolization for leiomyomas: perfusion and volume changes at MR imaging and relation to clinical outcome. Radiology 2002;222:367-374 https://doi.org/10.1148/radiol.2222010584
  19. Hecht EM, Do RK, Kang SK, Bennett GL, Babb JS, Clark TW. Diffusion-weighted imaging for prediction of volumetric response of leiomyomas following uterine artery embolization: a preliminary study. J Magn Reson Imaging 2011;33:641-646 https://doi.org/10.1002/jmri.22459
  20. Jain TP, Srivastava DN, Sahu RP, Thulkar S, Sharma S, Mittal S, et al. Uterine artery embolization for symptomatic fibroids with imaging follow up. Australas Radiol 2007;51:246-252 https://doi.org/10.1111/j.1440-1673.2007.01720.x

피인용 문헌

  1. RE: Uterine Fibroid Treatment Planning with the Diffusion Weighted Imaging Tool vol.14, pp.3, 2013, https://doi.org/10.3348/kjr.2013.14.3.547
  2. Feasibility study on energy prediction of microwave ablation upon uterine adenomyosis and leiomyomas by MRI vol.87, pp.1040, 2012, https://doi.org/10.1259/bjr.20130770
  3. A Case-Control Study of High-Intensity Focused Ultrasound Combined With Sonographically Guided Intratumoral Ethanol Injection in the Treatment of Uterine Fibroids vol.33, pp.4, 2012, https://doi.org/10.7863/ultra.33.4.657
  4. Research of dose-effect relationship parameters of percutaneous microwave ablation for uterine leiomyomas - a quantitative study vol.4, pp.None, 2012, https://doi.org/10.1038/srep06469
  5. Development of a Model for the Prediction of Treatment Response of Uterine Leiomyomas after Uterine Artery Embolization vol.15, pp.14, 2012, https://doi.org/10.7150/ijms.28687
  6. Uterine Artery Embolization for Leiomyomas and Adenomyosis: A Pictorial Essay Based on Our Experience from 1300 Cases vol.20, pp.10, 2019, https://doi.org/10.3348/kjr.2019.0205
  7. Uterine Fibroids and Adenomyosis: Imaging and Treatment vol.44, pp.22, 2012, https://doi.org/10.1097/01.cdr.0000795720.51837.27